Answers are grounded in this paper and cite their sources.
Experimental study reveals a novel heparin-binding cytokine that attracts and activates human monocytes, indicating dual chemotactic and antitumor-activating functions.
A novel basic heparin-binding monocyte chemotactic factor (MCF) was purified to homogeneity from the conditioned media of human myelomonocytic cell line THP-1 based on its in vitro monocyte chemotactic activity. The purified MCF was homogenous and estimated to be 15 kD on SDS-PAGE. Purified MCF stimulated normal human monocytes to be growth inhibitory in vitro at 2-3 d for several human tumor cell lines. This represents the first report of the identification and purification of a chemoattractant cytokine that also activates monocytes but is distinct from interferons and other known cytokines.
No takes yet. Share an insight, caveat, or question.
Matsushima et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: